News
While hydroxychloroquine (HCQ) helps reduce disease flares in lupus, its effect on renal function in patients with lupus ...
A new study found a high prevalence of chronic kidney disease (CKD) among people with systemic lupus erythematosus (SLE), ...
In this video exclusive, Leonard H. Calabrese, DO, chief medical editor of Healio Rheumatology, noted the ongoing efforts to define long COVID and recent data suggesting physicians are not treating ...
With this approval, pediatric patients aged five years and older with active lupus nephritis will have a first-of-its-kind treatment option for at-home administration. PHILADELPHIA-- (BUSINESS ...
From subtle rashes to sun-safety strategies, Drs Maureen McMahon and John Edminister discuss how to recognize cutaneous lupus and protect patients from UV-triggered flares.
Most lupus patients are women and many are Black women. They can suffer rashes, fatigue and kidney problems but may not know their big risk for heart disease.
The oral TLR 7/8 inhibitor showed clinically meaningful improvement in disease activity for patients with active lupus rash in a phase 2 study.
Katlyn Lenz-Zanis (left), of Burgettstown, with Dr. Jaime Miller, of Highland Park. Both women have lupus and lead Pittsburgh Lupus Support Group, a chapter of the Lupus Foundation of America.
Despite Merck KGaA’s lupus drug failing to prove itself against one form of the autoimmune disease, the German drugmaker has now shared the data to back up its belief that the therapy still has ...
“Lupus can make navigating everyday life difficult. The skin manifestation, known as lupus rash, often comes with persistent itching, which can lead to scarring and hair loss.
Cohort analyses from the WILLOW study reveal clear proof of concept in patients with CLE and SLE with active lupus rash, showing clinically meaningful improvement in disease activity at Week 16 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results